Skip to main content
Premium Trial:

Request an Annual Quote

Robert Bast, Danel Chan, Ian Jacobs, Joyce Schwartz, William Wallen, and Peter Leddy


Ciphergen Biosystems announced this week that it has established a scientific advisory board to help direct its product-development strategies.

There are five members in the advisory board:

Robert Bast, vice president for translational research and a professor at the University of Texas MD Anderson Center is best known for developing the Ovarian Cancer 125 monoclonal antibody that led to the production of the CA125 radioimmunoassay for the monitoring of epithelial ovarian cancer.

Danel Chan, a professor of pathology, oncology, urology, and radiology, and the director of the Center for Biomarker Discovery at the Johns Hopkins University School of Medicine is recognized for his work in finding and developing biochemical tumor markers, particularly for breast and prostate cancer.

Ian Jacobs, director of the Department of Gynecological Oncology and the Institute of Women's Health at University College London has conducted laboratory studies on the genetic basis of gynecological cancer, and headed the UK Collaborative Trial of Ovarian Cancer Screening involving 200,000 women in the UK.

Joyce Schwartz, vice president and chief laboratory officer of Quest Diagnostics is responsible for medical operations and medical quality for Quest's core laboratory testing business.

William Wallen is the senior vice president and chief scientific officer of Idexx Laboratories, a company that produces products and services for veterinary, food and water applications. Before joining Idexx, Wallen was senior vice president and head of the office of technology for the diagnostics division of Bayer Healthcare.

The Biotechnology Institute named Invitrogen's Peter Leddy to its board of directors, the organization said on Wednesday.

Leddy is senior vice-president of human resources, a position he's held since July 2005. Prior to Invitrogen, Leddy spent five years with Dell in several management positions, most recently vice-president of human resources for Americas Operations.

He received his BA in psychology from Creighton University and his MS and PhD in industrial/organizational psychology from the Illinois Institute of Technology.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.